| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 103746-25-4 | Miboplatin | C11H20N2O4Pt |
| 103747-72-4 | 2-Methoxy-N-(5-Methyl-4-Isoxazolyl)-Acetamide | |
| 103747-82-6 | N-Methyl-N-(5-Methyl-4-Isoxazolyl)-Acetamide | |
| 103747-86-0 | 1-(1,2-Dimethyl-1H-Imidazol-4-Yl)Ethanone | C7H10N2O |
| 103747-88-2 | 1-(1,2-Dimethyl-1H-Imidazol-5-Yl)Ethanone | C7H10N2O |
| 103748-04-5 | 2-{Methyl[2-Nitro-4-(Trifluoromethyl)Phenyl]Amino}Ethanol | C10H11F3N2O3 |
| 103748-25-0 | 1H-Benzimidazol-2-Amine, 5-Chloro-1-Methyl- | C8H8ClN3 |
| 103749-26-4 | 4-[(2,4-Dimethyl-3H-1,2,4-Triazol-2-Ium-3-Yl)Azo]-N,N-Dimethyl-Aniline Tetrafluoroborate | C12H19BF4N6 |
| 103750-03-4 | 5-Maleimidovaleric acid-NHS | C13H14N2O6 |
| 103752-63-2 | 5-[Hydroxy(4-Pyridinyl)Methyl]-2,4-Imidazolidinedione | C9H9N3O3 |
| 103753-78-2 | 3-(3,4-Dichlorophenyl)Dihydro-2(3H)-Furanone | C10H8Cl2O2 |
| 103754-08-1 | N-(2-Chlorobenzyl)-2-Propen-1-Amine | C10H12ClN |
| 103754-45-6 | 2-(2,4-Dichlorophenyl)-Butanedioic Acid | C10H8Cl2O4 |
| 103754-49-0 | 2,3-Dimethyl-1,4-Benzenedicarbonitrile | C10H8N2 |
| 103755-46-0 | 2-(1H-Indazol-3-Yl)Acetamide | C9H9N3O |
| 103755-50-6 | 8-Methoxy-6-Quinoxalinamine | C9H9N3O |
| 103755-54-0 | N-(1-Methyl-1H-Benzimidazol-7-Yl)Formamide | C9H9N3O |
| 103755-57-3 | 5-(4-Aminophenyl)-2,4-Dihydro-3H-Pyrazol-3-One | C9H9N3O |
| 103755-58-4 | (1-Phenyl-1H-1,2,3-triazol-4-yl)methanol | C9H9N3O |
| 103755-80-2 | 2,3,3,5,6,6-Hexamethyl-7-Oxa-2,5-Diazabicyclo[2.2.1]Heptane | C10H20N2O |
| 103762-93-2 | O-beta-D-Glucopyranosyl-(1→4)-O-beta-D-glucopyranosyl-(1→3)-O-beta-D-glucopyranosyl-(1→4)-D-glucose | C24H42O21 |
| 103765-01-1 | (alphaR)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide | C8H14N2O2 |
| 103765-03-3 | (R)-2-Aminobutanamide hydrochloride | C4H10N2O.HCl |
| 103765-33-9 | 5-Amino-3-Methyl-2,4-Thiophenedicarboxylic Acid 2,4-Dimethyl Ester | C9H11NO4S |
| 103766-07-0 | 21beta-[2-O-(beta-D-Glucopyranosyl)-beta-D-Glucopyranosyloxy]-3beta,23-Dihydroxyolean-12-En-28-Oic Acid | C42H68O15 |
| 103766-25-2 | Gimeracil | C5H4ClNO2 |
| 103767-48-2 | 3-(3-(6-Benzoyloxy-3-cyano-2-pyridyloxycarbonyl)benzoyl)-3'-O-benzyl-2'-deoxy-5-fluorouridine | C37H27FN4O10 |
| 103768-99-6 | 3-(2-Hydroxyethyl)thiazolium bromide | C5H8BrNOS |
| 103769-63-7 | 7,10,12-Trimethyl-6H-Oxazolo[4,5-g]pyrido[4,3-b]carbazolium | C19H16N3O |
| 103769-72-8 | N2,N2-Dinitro-2,5-Pyridinediamine | C5H5N5O4 |
| 103769-76-2 | N,N'-Dinitro-2,5-Pyridinediamine | C5H5N5O4 |
| 103771-11-5 | N-(6-Aminohexyl)-5-Iodonaphthalene-1-Sulfonamide | C16H21IN2O2S |
| 103771-14-8 | N-(8-Aminooctyl)-5-Iodonaphthalene-1-Sulfonamide | C18H25IN2O2S |
| 103772-04-9 | 2-Methoxy-1-Pyrrolidinecarboxamide | C6H12N2O2 |
| 103772-10-7 | 2,3,4,5-Tetrafluoro-6-Nitrobenzoyl Chloride | C7ClF4NO3 |
| 103772-12-9 | Ethyl 1-Cyclopropyl-6,7,8-Trifluoro-5-Nitro-4-Oxo-1,4-Dihydro-3-Quinolinecarboxylate | C15H11F3N2O5 |
| 103772-13-0 | Ethyl 5-Amino-1-Cyclopropyl-6,7,8-Trifluoro-4-Oxo-1,4-Dihydro-3-Quinolinecarboxylate | C15H13F3N2O3 |
| 103772-14-1 | 5-Amino-1-Cyclopropyl-6,7,8-Trifluoro-4-Oxo-1,4-Dihydro-3-Quinolinecarboxylic Acid | C13H9F3N2O3 |
| 103773-42-8 | (2E)-3-(2,2-Dimethyl-1,3-Dioxolan-4-Yl)Acrylaldehyde | C8H12O3 |
| 103773-62-2 | Ganoderic acid C 2 | C30H46O7 |
| 103775-10-6 | Moexipril | C27H34N2O7 |
| 103775-14-0 | Moexiprilat | C25H30N2O7 |
| 103775-61-7 | (2R)-2-Hydroxypropyl 4-Methylbenzenesulfonate | C10H14O4S |
| 103775-75-3 | Miboplatin | C11H18N2O4Pt |
| 103776-28-9 | 4-Isopropyl-1-Propyl-2-Azetidinone | C9H17NO |
| 103780-20-7 | Restrictionendodeoxyribo-Nuclease NotI | |
| 103781-89-1 | Methyl 6-(Benzyloxy)-1H-Indole-2-Carboxylate | C17H15NO3 |
| 103782-08-7 | Allosamidin | C25H42N4O14 |
| 103782-76-9 | 2-Ethyl-2-(hydroxymethyl-d)-1,3-propane-1,1,3,3-d4-diol | C6H9D5O3 |
| 103784-04-9 | 1-(3-Bromopropyl)-1,3-dihydro-2H-benzimidazol-2-one | C10H11BrN2O |